Health-related quality of life in HIV patients switching to twice-daily indinavir/ritonavir regimen or continuing with three-times-daily indinavir-based therapy

Antiviral Therapy

Volumn 9, Issue 6, 2004, Pages 979-985

  Badía, Xavier ^a,b   Podzamczer, Daniel ^c   Moral, Irene ^b   Roset, Montse ^b   Arnaiz, Joan A ^d   Loncà, Montse ^d   Casiró, Arnaldo ^e   Rosón, Beatriz ^c   Gatell, Jose M ^d  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^b HO Statistics and Modelling   (Spain)

^c HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^d HOSPITAL CLÍNIC   (Spain)

^e Hospital General De Agudos Teodoro Alvarez   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

INDINAVIR; RITONAVIR;

ADULT; ARTICLE; FEMALE; HEALTH; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; PAIN; PATIENT COMPLIANCE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; ROLE PLAYING; SOCIAL INTERACTION; VIRUS LOAD;

ADULT; ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HIV-1; HUMANS; INDINAVIR; MALE; QUALITY OF LIFE; REVERSE TRANSCRIPTASE INHIBITORS; RITONAVIR; TREATMENT OUTCOME; VIRAL LOAD;

EID: 11144275176     PISSN: 13596535     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Gatell JM, Clotet B, Podzamczet D, Mito JM & Mallolas J. Guía práctica del SIDA. Clínica, diagnóstico y tratamiento (Practical AIDS guide. Clinical, diagnosis and treatment). 1998. Barcelona: Masson.
2. Yeni PG, Hammer MS, Carpenter CCJ, Cooper DA, Fischl MA, Gatell JM, Gazzard BG, Hirsch MS, Jacobsen DM, Katzenstein DA, Montaner JSG, Richman DD, Saag MS, Schechter M, Schooley RT, Thompson MA, Vell S & Volberding PA. Antiretroviral treatment for adult HIV infection in 2002: updated recommendations of the International AIDS Society-USA Panel. Journal of the America! Medical Association 2002; 288:222-235.
3. Roca B & Simón E. [Antiretroviral medication]. Jano 1998; 54:387-401. Spanish.
4. Plosker GL & Noble S. Indinavir: a review of its use in the management of HIV infection. Drugs 1999; 58:1165-1203.
5. Hammer SM, Squires KE, Hughes MD, Grimes JM, Demeter LM, Currier JS, Eron JJ, Feinberg JE, Balfour HH, Deyton LR, Chodakewitz JA & Fischl MA. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infections and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trial Group 320 Study Team. New England Journal of Medicine 1997; 337:725-733.
6. Gulick RM, Mellors JW, Havlir D, Eron JJ, Gonzalez C, McMahon D, Richman DD, Valentine FT, Jonas L, Meibohm A, Emini FA & Chidakewitz JA. Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy. New England Journal of Medicine 1997; 337:734-739.
7. Palella FJ Jr, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, Aschman DJ & Holmberg SD. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. New England Journal of Medicine 1998; 338:853-860.
8. Burger DM, Hoetelmans RM, Hugen PW, Mulder JW, Meenhorst PL, Koopmans PP, Brinkman K, Keuter M, Dolmans W & Hekster YA. Low plasma concentrations of indinavir are related to virological treatment failure in HlV-1-infected patients on indinavir-containing triple therapy. Antiviral Therapy 1998; 3:215-220.
9. Arnaiz JA, Mallolas J, Podzamczer D, Gerstoft J, Lundgren JD, Cahn P, Fätkenheuer G, D'Arminio-Monforte A, Casiro A, Reiss P, Burger DM, Stek M & Gatell JM for the BEST Study Team. Continued indinavir versus switching to indinavir/ritonavir in HIV-infected patients with suppressed viral load. AIDS 2003; 17:831-840.
10. Puigventós F, Riera M, Delibes C, Peñaranda M, De la Fuente L & Boronat A. [Adherence to antiretroviral drug therapy. A systematic review]. Medicina Clinica 2002; 119:130-137. Spanish.
11. Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents. Available at: http://hivatis.org/trtgdlns.html#Adult
12. Wright MT. The old problem of adherence: research on treatment adherence and its relevance for HIV/AIDS. AIDS Care 2000; 12:703-710.
13. Golin CE, Liu H, Hays RD, Miller LG, Beck CK, Ickovics J, Kaplan AH & Wenger NS. A prospective study of predictors of adherence to combination antiretroviral medication. Journal of General Internal Medicine 2002; 17:756-765.
14. Stone VE, Hogan JW, Schuman P, Rompalo AM, Howard AA, Korkontzelou C & Smith DK (HERS STUDY). Antiretroviral regimen complexity, self-reported adherence, and HIV patients' understanding of their regimens: survey of women in the her study. Journal of Acquired Immune Deficiency Syndromes 2001; 28:124-131.
15. Cohen C, Revicki DA, Nabulsi A, Sarocco PW & Jiang P. A randomized trial of the effect of ritonavir in maintaining quality of life in advanced HIV disease. Advanced HIV Disease Ritonavir Study Group. AIDS 1998; 12:1495-1502.
16. Miners AH, Sabin CA, Mocroft A, Youle M, Fisher M & Johnson M. Health-related quality of life in individuals infected with HIV in the era of HAART. HIV Clinical Trials 2001; 2:484-492.
17. Wu AW, Rubin HR, Mathews WC, Ware JE, Brysk LT, Hardy WD, Bozzette SA, Spectot SA & Richman DD. A health status questionnaire using 30 items from the Medical Outcomes Study. Preliminary validation in persons with early HIV infection. Medical Care 1991; 29:786-798.
18. Wu AW, Hays RD, Kelly S, Malitz F & Bozzette SA. Applications of the Medical Outcomes Study health-related quality of life measures in HIV-AIDS. Quality of Life Research 1997b; 6:531-554.
19. Wu AW, Revicki DA, Jacobson D & Malitz FE. Evidence for reliability, validity and usefulness of the Medical Outcomes Study HIV Health Survey (MOS-HIV). Quality of Life Research 1997c; 6:481-493.
20. Shag AC, Ganz PA, Kahn B & Petersen L. Assessing the needs and quality of life in patients with HIV infection: development of the HIV Overview of Problems-Evaluation System (HOPES). Quality of Life Research 1992; 1:397-413.
21. Ganz PA, Schag AC, Kahn B & Petersen L. Assessing the quality of life of HIV infected persons: clinical and descriptive information from studies with the HOPES. Psychology & Health 1994; 9:93-110.
22. Badia X, Podzamczer D, Garcia M, López-Lavid C, Consiglio E & the Spanish MOS-HIV and MQOL-HIV Validation Group. A randomized study comparing instruments for measuring health-related quality of life in HIV infected patients. AIDS 1999; 13:1727-1735.
23. Badia X, Herdman M, Rovira S & Garcia M. [The translation and cultural adaptation into Spanish of the MOS-HIV questionnaire to evaluate the quality of life in HIV-infected patients. Final report ISP-1073]. June 1997. Institute Universitario de Salud Pública de Cataluña. Spanish.
24. Delate T & Coons SJ. The use of 2 health-related quality-of-life measures in a sample of persons infected with human immunodeficiency virus. Clinical Infectious Diseases 2001; 32:E47-52.
25. Casado A, Consiglio E, Podzamczer D & Badia X. Highly active antiretroviral treatment (HAART) and health related quality of life in naive and pretreated HIV-infected patients. HIV Clinical Trials 2001; 2:477-483.
26. Bonfanti P, Valsecchi L, Parazzini F, Carradori S, Pusterla L, Fortuna P, Timillero L, Alessi F, Ghiselli G, Gabbuti A, Di Cintio E, Martinelli C, Faggion I, Landonio S & Quirino T. Incidence of adverse reactions in HIV patients treated with protease inhibitors: a cohort study. Coordinamento Italiano Sutdio Allergia e Infezione da HIV (CISAI) Group. Journal of Acquired Immune Deficiency Syndromes 2000, 23:236-245.
27. Barreiro P, Soriano V, Oiler V & Gonzalez-Lahoz J. Potent activity but limited tolerance of ritonavir plus indivanir in salvage interventions. Journal of Acquired Immune Deficiency Syndromes 2000; 24:488.
28. Penedo FJ, Gonzalez JS, Dahn JR, Antoni M, Malow R, Costa P & Schneiderman N. Personality, quality of life and HAART adherence among men and women living with HIV/AIDS. Journal of Psychosomatic Research 2003; 54:271-278.